语种
英语
来源机构
Karolinska Institutet; Uppsala University; Uppsala University; Karolinska Institutet; Karolinska Institutet
资助信息
The PRIMROSE trial has been supported by grants from: the Swedish Research Council for Health, Working Life and Welfare (2006-0226 and 2011-0413), the Swedish Research Council (K2006-27X-20069-01-3 and K2012-69X-22058-01-3), the Research and Development Committee, Stockholm County Council (2006-0324), the Regional Research Council of the Uppsala and Orebro Healthcare Region (RFR-12404), Uppsala County Council, Sormland County Council, the Public Health Committee of Stockholm County Council (0803-377), the Vardal Foundation (B2007-006), AFA Insurance (H-06:05/070001), the Foundation of the Swedish Diabetes Society (TMA2006-004), and the Karolinska Healthcare Sciences Postgraduate School (2008). The trial has also received faculty funds from the Karolinska Institutet for PhD student grants (2012 and 2013). The fun-ders had no role in the design of the study or the collection, analysis, and interpretation of data, and did not take part in the writing of the manuscript;The Swedish Research Council and the Karolinska Healthcare Sciences Postgraduate School;THe Swedish Research Council for Health, Working Life and Welfare, Swedish Research Council, Research and Development Committee, Stockholm County Council, the Regional Research Council of the Uppsala and Orebro Healthcare Region, Vardal Foundation, AFA Insurance, the Foundation of the Swedish Diabetes Society;THe Swedish Research Council for Health, Working Life and Welfare, Swedish Research Council, Research and Development Committee, Stockholm County Council, the Regional Research Council of the Uppsala and Orebro Healthcare Region, Vardal Foundation, AFA Insurance, the Foundation of the Swedish Diabetes Society.
被引频次(WOS)
0
被引频次(其他)
0
180天使用计数
2
2013以来使用计数
3
EISSN
1748-2631
出版年
2022-12-31
DOI
10.1080/17482631.2022.2096123